- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor Heterogeneity in Colorectal Cancer: What Do We Know So Far?
Authors
Keywords
-
Journal
PATHOBIOLOGY
Volume 85, Issue 1-2, Pages 72-84
Publisher
S. Karger AG
Online
2018-02-08
DOI
10.1159/000486721
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications
- (2017) Jessica Roelands et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016
- (2017) Alessandro Lugli et al. MODERN PATHOLOGY
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy
- (2016) Etienne Becht et al. CLINICAL CANCER RESEARCH
- Methylator phenotype in colorectal cancer: A prognostic factor or not?
- (2016) C. Gallois et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Poorly differentiated clusters (PDC) in colorectal cancer: what is and ought to be known
- (2016) Luca Reggiani Bonetti et al. Diagnostic Pathology
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
- (2016) Bernhard Mlecnik et al. IMMUNITY
- PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes
- (2016) Matthew W Rosenbaum et al. MODERN PATHOLOGY
- The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis
- (2016) Bernhard Mlecnik et al. Science Translational Medicine
- Current and future biomarkers in the treatment of colorectal cancer
- (2016) Pieter-Jan Cuyle et al. ACTA CLINICA BELGICA
- Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis
- (2015) L De Smedt et al. BRITISH JOURNAL OF CANCER
- Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity
- (2015) T.-M. Kim et al. CLINICAL CANCER RESEARCH
- A Big Bang model of human colorectal tumor growth
- (2015) Andrea Sottoriva et al. NATURE GENETICS
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
- (2015) Noemi Andor et al. NATURE MEDICINE
- Advances in the care of patients with mucinous colorectal cancer
- (2015) Niek Hugen et al. Nature Reviews Clinical Oncology
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reconciliation of classification systems defining molecular subtypes of colorectal cancer
- (2014) Anguraj Sadanandam et al. CELL CYCLE
- Evolving concepts of tumor heterogeneity
- (2014) Victoria R Zellmer et al. Cell and Bioscience
- Signet Ring Cell Colorectal Carcinoma
- (2013) Douglas J. Hartman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Mucinous and Signet-Ring Cell Colorectal Cancers Differ from Classical Adenocarcinomas in Tumor Biology and Prognosis
- (2013) Ulrich Nitsche et al. ANNALS OF SURGERY
- Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
- (2013) Raoul A. Droeser et al. EUROPEAN JOURNAL OF CANCER
- Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition
- (2013) Paul Roepman et al. INTERNATIONAL JOURNAL OF CANCER
- Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
- (2013) Eva Budinska et al. JOURNAL OF PATHOLOGY
- Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
- (2013) Felipe De Sousa E Melo et al. NATURE MEDICINE
- A colorectal cancer classification system that associates cellular phenotype and responses to therapy
- (2013) Anguraj Sadanandam et al. NATURE MEDICINE
- PTEN Loss Increases PD-L1 Protein Expression and Affects the Correlation between PD-L1 Expression and Clinical Parameters in Colorectal Cancer
- (2013) Minmin Song et al. PLoS One
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
- (2013) Laetitia Marisa et al. PLOS MEDICINE
- Clinicopathology and Outcomes for Mucinous and Signet Ring Colorectal Adenocarcinoma: Analysis from the National Cancer Data Base
- (2012) John R. Hyngstrom et al. ANNALS OF SURGICAL ONCOLOGY
- Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer
- (2012) Milo Horcic et al. HUMAN PATHOLOGY
- Association ofKRASG13D Tumor Mutations With Outcome in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy With or Without Cetuximab
- (2012) Sabine Tejpar et al. JOURNAL OF CLINICAL ONCOLOGY
- MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes
- (2012) Lawrence A Donehower et al. JOURNAL OF PATHOLOGY
- Cancer classification using the Immunoscore: a worldwide task force
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- The immune score as a new possible approach for the classification of cancer
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intra- and Inter-Tumor Heterogeneity of BRAFV600EMutations in Primary and Metastatic Melanoma
- (2012) Molly Yancovitz et al. PLoS One
- Intramural and extramural vascular invasion in colorectal cancer
- (2011) Johannes Betge et al. CANCER
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Microsatellite instability in metastatic colorectal cancer: a review of pathology, response to chemotherapy and clinical outcome
- (2011) Kein-Leong Yim MEDICAL ONCOLOGY
- Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients
- (2010) Vanessa Deschoolmeester et al. BMC IMMUNOLOGY
- The relationship between serum vascular endothelial growth factor A and microsatellite instability in colorectal cancer
- (2010) T. F. Hansen et al. Colorectal Disease
- Microsatellite instability in colorectal cancer—the stable evidence
- (2010) Eduardo Vilar et al. Nature Reviews Clinical Oncology
- Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis
- (2009) Gaëtan Des Guetz et al. EUROPEAN JOURNAL OF CANCER
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphovascular Invasion in Colorectal Cancer
- (2008) Elizabeth I. Harris et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation